- Home
- CNSP vs EVOK Comparison
CNSP vs EVOK Comparison
Compare CNSP & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- EVOK
- Stock Information
- Founded
- CNSP 2017
- EVOK 2007
- Country
- CNSP United States
- EVOK United States
- Employees
- CNSP N/A
- EVOK N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- CNSP Health Care
- EVOK Health Care
- Exchange
- CNSP Nasdaq
- EVOK Nasdaq
- Market Cap
- CNSP 5.4M
- EVOK 4.3M
- IPO Year
- CNSP 2019
- EVOK 2013
- Fundamental
- Price
- CNSP $0.11
- EVOK $4.58
- Analyst Decision
- CNSP Strong Buy
- EVOK
- Analyst Count
- CNSP 1
- EVOK 0
- Target Price
- CNSP $0.50
- EVOK N/A
- AVG Volume (30 Days)
- CNSP 41.4M
- EVOK 1.2M
- Earning Date
- CNSP 11-15-2024
- EVOK 11-07-2024
- Dividend Yield
- CNSP N/A
- EVOK N/A
- EPS Growth
- CNSP N/A
- EVOK N/A
- EPS
- CNSP N/A
- EVOK N/A
- Revenue
- CNSP N/A
- EVOK $8,617,036.00
- Revenue This Year
- CNSP N/A
- EVOK $124.10
- Revenue Next Year
- CNSP N/A
- EVOK $75.70
- P/E Ratio
- CNSP N/A
- EVOK N/A
- Revenue Growth
- CNSP N/A
- EVOK 100.35
- 52 Week Low
- CNSP $0.10
- EVOK $3.54
- 52 Week High
- CNSP $137.50
- EVOK $17.40
- Technical
- Relative Strength Index (RSI)
- CNSP 37.06
- EVOK 39.65
- Support Level
- CNSP $0.10
- EVOK $4.03
- Resistance Level
- CNSP $0.13
- EVOK $6.09
- Average True Range (ATR)
- CNSP 0.02
- EVOK 0.58
- MACD
- CNSP 0.00
- EVOK -0.20
- Stochastic Oscillator
- CNSP 8.50
- EVOK 20.52
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.